TWI766184B - A kind of Lactobacillus plantarum and its use for preparing vegetable condensed yogurt and improving intestinal flora - Google Patents

A kind of Lactobacillus plantarum and its use for preparing vegetable condensed yogurt and improving intestinal flora Download PDF

Info

Publication number
TWI766184B
TWI766184B TW108131848A TW108131848A TWI766184B TW I766184 B TWI766184 B TW I766184B TW 108131848 A TW108131848 A TW 108131848A TW 108131848 A TW108131848 A TW 108131848A TW I766184 B TWI766184 B TW I766184B
Authority
TW
Taiwan
Prior art keywords
yogurt
bcrc
deposit number
vegetable
lactic acid
Prior art date
Application number
TW108131848A
Other languages
Chinese (zh)
Other versions
TW202111112A (en
Inventor
謝佳雯
楊逸善
吳昇燕
Original Assignee
歐斐生
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 歐斐生 filed Critical 歐斐生
Priority to TW108131848A priority Critical patent/TWI766184B/en
Publication of TW202111112A publication Critical patent/TW202111112A/en
Application granted granted Critical
Publication of TWI766184B publication Critical patent/TWI766184B/en

Links

Images

Landscapes

  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Beans For Foods Or Fodder (AREA)

Abstract

一種新穎植物乳桿菌(Lactobacillus plantarum)菌株,其係寄存於中華民國食品工業發展研究所,寄存編號為BCRC910891,及寄存於中國微生物菌種保藏管理委員會普通微生物中心,寄存編號為CGMCC17716,該植物乳桿菌加入植物漿可以製備口感佳、營養價值高的植物性凝態優格,植物性凝態優格中具有高含量伽瑪胺基丁酸、去醣基異黃酮,該植物性凝態優格可以改善健康人與糖尿病患的腸道菌相,改善腸道菌相是指增加有益菌、伺機菌,尤其可以增加腸道中的艾克曼嗜黏蛋白菌。 A novel Lactobacillus plantarum strain, which is deposited in the Food Industry Development Research Institute of the Republic of China, with the deposit number BCRC910891, and deposited in the General Microorganism Center of the China Microorganism Culture Collection and Management Committee, with the deposit number CGMCC17716, the plant milk Bacillus can be added to plant pulp to prepare vegetable condensed yogurt with good taste and high nutritional value. The vegetable condensed yogurt has high content of gamma aminobutyric acid and deglycosyl isoflavones. It can improve the intestinal flora of healthy people and diabetic patients. Improving the intestinal flora refers to increasing beneficial bacteria and opportunistic bacteria, especially Ekman Mucophilus in the intestine.

Description

一種植物乳桿菌及其製備植物性凝態優格、改善腸道菌相的用途 A kind of Lactobacillus plantarum and its use for preparing vegetable condensed yogurt and improving intestinal flora

本發明係關於一種植物乳桿菌可以用於製備植物性凝態優格,具有改善腸道菌相的功效。 The present invention relates to a Lactobacillus plantarum that can be used for preparing vegetable condensed yogurt, and has the effect of improving intestinal bacteria.

乳酸菌(Lactic acid bacteria;LAB)為泛指可將醣類轉換成以乳酸為主要代謝物的微生物總稱。乳酸菌被廣泛的應用在全世界的傳統食品中,被公認為安全(General Recognized as Safe;GRAS)的微生物菌種。 Lactic acid bacteria (LAB) is a general term for microorganisms that can convert sugars into lactic acid as the main metabolite. Lactic acid bacteria are widely used in traditional foods all over the world, and are generally recognized as safe (General Recognized as Safe; GRAS) microbial strains.

乳酸菌可提供發酵食品的製造以及風味,主要透過三種代謝路徑,包括:糖解反應(發酵醣類)、脂解反應(降解脂肪)、蛋白質分解反應(分解蛋白質為小分子胜肽或胺基酸)。乳酸是主要醣類代謝後的結果,但部分微生物菌株,會將中間代謝產物如丙酮酸,再轉換成二乙醯基(diacetyl)、乙醯甲基甲醇(acetoin)、乙酸乙酯(acetaldehyde)或及醋酸(acetic acid),成為常見乳製品乳酸發酵的酸味主要來源;但是蛋白質類的乳酸發酵食品,主要的風味,是來自蛋白質降解過程中所產生的揮發性氣體,包括不同的醇類(alcohols)、醛類(aldehydes)、酯類(esters)等。 Lactic acid bacteria can provide the manufacture and flavor of fermented food mainly through three metabolic pathways, including: glycolysis (fermentation of sugars), lipolysis (degradation of fat), and proteolysis (decomposition of proteins into small molecular peptides or amino acids) ). Lactic acid is the result of the main carbohydrate metabolism, but some microbial strains convert intermediate metabolites such as pyruvate into diacetyl, acetoin, and acetaldehyde. Or acetic acid, which has become the main source of sour taste in lactic acid fermentation of common dairy products; however, the main flavor of protein-based lactic acid fermentation food comes from the volatile gases generated during protein degradation, including different alcohols ( alcohols), aldehydes, esters, etc.

雖然市售乳酸菌食品中,以動物奶作為發酵主原料製作而成的優格(yogurt)或是優格飲(drink yogurt)為大宗。然而根據統計指出,全球乳糖不耐症人口數高達70%,其中亞洲人更高達95%。此外,因信仰而選擇不使用乳製品的蔬食或素食人口,提供乳酸菌的蛋白質發酵食品,成為替 代動物奶的優格食品的開發趨勢。 Although commercially available lactic acid bacteria foods, yogurt or drink yogurt made from animal milk as the main raw material for fermentation is the bulk. However, according to statistics, the number of people with lactose intolerance in the world is as high as 70%, of which Asians are as high as 95%. In addition, for vegetarians or vegetarians who choose not to use dairy products because of their beliefs, protein fermented foods that provide lactic acid bacteria have become an alternative. Trends in the development of yogurt as a substitute for animal milk.

乳酸菌培養於蛋白質溶液中,由乳酸菌釋放出的有機酸,造成的pH值下降,同時會造成蛋白質分子間的凝集,而形成凝結狀態。此狀態出現於優格製品中,易受到pH、溫度、外力等變化,而造成不同程度的離水現象,嚴重的離水現象,導致產品外觀缺失以及品質變異等不同程度的影響。市售凝乳產品中,為減少凝結的離水現象,常透過額外添加固形物(利入乳清蛋白等)或是添加穩定劑(例如變性澱粉、果膠、洋菜膠等)加以改善。 When lactic acid bacteria are cultivated in protein solution, the organic acid released by lactic acid bacteria will cause the pH value to drop, and at the same time, it will cause the aggregation of protein molecules to form a coagulation state. This state occurs in yogurt products, and is susceptible to changes in pH, temperature, external force, etc., resulting in different degrees of water separation, serious water separation, resulting in product appearance loss and quality variation. In commercial curd products, in order to reduce the phenomenon of coagulation from water, it is often improved by adding additional solids (increasing whey protein, etc.) or adding stabilizers (such as modified starch, pectin, agarin, etc.).

部分乳酸菌,在特定的比例以及培養條件下,可以生產出細胞外多醣體(exopolysaccharides;EPS)結構可以減緩蛋白質凝結的離水現象,進而改善質地及口感。然而隨著乳酸菌菌種以及培養條件的差異,這些胞外多醣體的產量、組成以及性質有極大的差異。部分菌種的胞外多醣,可協助菌株的抵抗腸胃道的酸鹼值,而安全存活於腸胃道。 Some lactic acid bacteria can produce exopolysaccharides (EPS) structures under specific ratios and culture conditions, which can slow down the phenomenon of water separation from protein coagulation, thereby improving texture and taste. However, with the difference of lactic acid bacteria species and culture conditions, the yield, composition and properties of these exopolysaccharides vary greatly. The extracellular polysaccharides of some strains can help the strains resist the pH value of the gastrointestinal tract and survive safely in the gastrointestinal tract.

「腦腸軸線」(gut-brain axis),是腸道與腦相互聯絡的重要途徑,其中腸道中的微生物扮演重要的角色,包括,腸躁症、憂鬱症、焦慮症、自閉症、慢性疲勞、第二型糖尿病等盛行率極高的疾病,都和腦腸軸線相關。人類腸道的細菌門,以厚壁菌門(Firmicutes)、擬桿菌門(Bacteroidetes)佔極高比例,其次是放線菌門(Actinobacteria)、變形菌門(Proteobacteria)、梭桿菌門(Fusobacteria)以及疣微菌門(Verrucobacteria)等,隨著居住地域以及飲食、健康狀況不同,可被分析出多達50門的分類。 The "gut-brain axis" is an important way for the gut and the brain to communicate with each other, in which the microbes in the gut play an important role, including irritable bowel disorder, depression, anxiety, autism, chronic Fatigue, type 2 diabetes and other diseases with a high prevalence are all related to the brain-gut axis. The bacterial phyla in the human gut are dominated by Firmicutes and Bacteroidetes, followed by Actinobacteria, Proteobacteria, Fusobacteria and Verrucobacteria, etc., can be classified into as many as 50 phyla depending on the living area, diet, and health status.

腸道微生物的動態與人體間的互動關係,常以有益菌、有害菌以及伺機性,其中伺機性的微生物,是隨著有益菌和有害菌的比例改變, 而有所改變,當有益菌比例高過有害菌時,伺機性微生物的比例隨著提升;反之亦然。 The interaction between the dynamics of gut microbes and the human body is often characterized by beneficial bacteria, harmful bacteria, and opportunistic microorganisms. Among them, opportunistic microorganisms change with the ratio of beneficial and harmful bacteria. However, when the proportion of beneficial bacteria is higher than that of harmful bacteria, the proportion of opportunistic microorganisms increases; and vice versa.

腸道微生物中常被認為有益菌包括:雙崎桿菌目(Bifidobacteriales)中的兩叉雙歧桿菌(Bifidobacterium bifidum)、假長雙歧桿菌(Bifidobacterium pseudolongum)、動物雙崎桿菌(Bifidobacterium animalis)、熱嗜酸性雙崎桿菌(Bifidobacterium thermacidophilum)、短雙崎桿菌(Bifidobacterium breve)、青春雙崎桿菌(Bifidobacterium adolescentis)、長雙崎桿菌(Bifidobacterium longum)等;乳酸菌科(Lactobacillaceae)中的洛德乳桿菌(Lactobacillus reuteri)、植物乳桿菌(Lactobacillus plantarum)、唾液乳酸桿菌(Lactobacillus salivarius)、類植物乳桿菌(Lactobacillus paraplantarum)、嗜酸乳桿菌(Lactobacillus acidophilus)、保加利亞乳酸桿菌(Lactobacillus delbrueckii bulgaricus)、短乳酸桿菌(Lactobacillus brevis)、乾酪乳酸桿菌(Lactobacillus casei)、加氏乳酸桿菌(Lactobacillus gasseri)、瑞士乳酸桿菌(Lactobacillus helveticus)、詹氏乳酸桿菌(Lactobacillus jensenii)等;疣微菌門(Verrucobacteria)的艾克曼嗜黏蛋白菌(Akkermansia muciniphila)等。 Commonly considered beneficial bacteria in gut microbes include: Bifidobacterium bifidum , Bifidobacterium pseudolongum , Bifidobacterium animalis, Bifidobacterium animalis , Bifidobacterium bifidum in the order Bifidobacteriales Bifidobacterium thermoacidophilum , Bifidobacterium breve , Bifidobacterium adolescentis , Bifidobacterium longum , etc.; Lactobacillus in Lactobacillaceae reuteri ), Lactobacillus plantarum , Lactobacillus salivarius , Lactobacillus paraplantarum , Lactobacillus acidophilus , Lactobacillus delbrueckii bulgaricus , Lactobacillus delbrueckii bulgaricus Lactobacillus brevis ), Lactobacillus casei ( Lactobacillus casei ), Lactobacillus gasseri ( Lactobacillus gasseri ), Lactobacillus helveticus ( Lactobacillus helveticus ), Lactobacillus jensenii ( Lactobacillus jensenii ) etc .; Mucinophilic bacteria ( Akkermansia muciniphila ) and so on.

腸道微生物中常被認為有害菌包括:困難梭狀芽孢菌(Clostridium difficilie)、產氣梭狀芽孢桿菌(Clostridium perfringes)、病原性大腸桿菌(Esxcherichia coli)、金黃色葡萄球菌(Staphylococcus aureus)、綠膿桿菌(Pseudomonas aeruginosa)、克雷白氏桿菌(Klebseilla)、沙門氏桿菌(Salmonella)、志賀氏桿菌(Shigella)、曲狀桿菌(Campylobacter)、霍亂弧菌(Vibrio cholerae)、仙人掌桿菌(Bacillus cereus)、細梭菌(Fusobacteria)、鏈球 菌(Streptococcus)等。 The gut microbes that are often considered harmful include: Clostridium difficilie , Clostridium perfringes , pathogenic Escherichia coli , Staphylococcus aureus , green Pseudomonas aeruginosa , Klebseilla , Salmonella , Shigella , Campylobacter , Vibrio cholerae , Bacillus cereus ), Clostridium ( Fusobacteria ), Streptococcus ( Streptococcus ), etc.

因此,透過飲食或是藥物,維持或是促進健康的腸道菌群,維持較高比例的益生菌是值得期待的。目前對於為何透過特定的膳食補充可以提昇動物體內的有益菌的比例機制尚未了解,因此,對於何種益生菌、或是何種組合的益生菌,在何種的基質下進行發酵後的產物,對於提昇動物腸道內有益菌的比例,仍需進行探討。有鑑於此,本發明的目的,在於提供一種可以提昇動物體內有益菌比例的植物性發酵產物及其應用。 Therefore, maintaining or promoting a healthy intestinal flora through diet or medicine is worth looking forward to maintaining a higher proportion of probiotics. At present, the mechanism of why the proportion of beneficial bacteria in animals can be increased through specific dietary supplements is still unknown. Therefore, what kind of probiotics, or what combination of probiotics, and what kind of substrate is used for fermentation products, There is still a need to explore how to increase the proportion of beneficial bacteria in the animal gut. In view of this, the purpose of the present invention is to provide a plant fermentation product that can increase the ratio of beneficial bacteria in animals and its application.

在腸道中的有益菌群中,艾克曼嗜黏蛋白菌(Akkermansia muciniphila)為一個被認為重要的菌種。艾克曼嗜黏蛋白菌為絕對厭氧,且在動物體內以腸黏膜蛋白為唯一碳源及氮源的細菌,首次報導是在2004年由荷蘭學者Willemde Vos實驗室發現並且鑑定出來的。這個細菌在人體內的含量很豐富,可以高達1-3%。由於其可分解腸黏膜蛋白,因此對於影響緊生長於腸黏下的腸內皮細胞的生理性。自2007年開始,陸續的研究發現,艾克曼嗜黏蛋白菌可能是一個具有生理功能且值得應用開發的次世代益生菌菌種。目前已經知道艾克曼嗜黏蛋白菌與很多健康問題有負相關性,例如艾克曼嗜黏蛋白菌越少的個體,越容易發胖、出現發炎症狀和第二型糖尿病等;腸道內的艾克曼嗜黏蛋白菌越多的動物個體,肥胖、發炎症狀和2型糖尿病的比例相對減少糖尿病鼠糞便中艾克曼嗜黏蛋白菌,會較正常鼠降低到3000倍以下;肥胖鼠糞便中艾克曼嗜黏蛋白菌,會較正常鼠降低到100倍以下。艾克曼嗜黏蛋白菌在高脂飲食的小鼠腸道內生長,可保護小鼠免於因高脂飲食引起的代謝與免疫風險,艾克曼嗜黏蛋白菌在人體內存在的比例,對於增加癌症免疫治療效果上有非常顯著的作用。因此,提供適 當的飲食提昇腸胃道中艾克曼嗜黏蛋白菌的數量,預期對於維持身體健康狀況有所助益。 Among the beneficial flora in the gut, Akkermansia muciniphila is considered to be an important species. Ekmanmucinophilus is an absolutely anaerobic bacterium that uses intestinal mucosal proteins as the sole carbon and nitrogen source in animals. It was first reported in 2004 by the laboratory of Dutch scholar Willemde Vos. This bacterium is abundant in the human body and can be as high as 1-3%. Because it can decompose intestinal mucosal proteins, it can affect the physiology of intestinal endothelial cells that grow tightly under the intestinal mucosa. Since 2007, successive studies have found that Ekman Mucophilus may be a next-generation probiotic strain with physiological functions and worthy of application and development. It is now known that Ekmanella is negatively associated with many health problems. For example, individuals with less Ekmanophilus are more likely to gain weight, develop inflammatory symptoms, and type 2 diabetes. The more animals with more Ekmania muciniphila, the proportion of obesity, inflammatory symptoms and type 2 diabetes is relatively reduced. The Ekmani mucinophilus in the feces of diabetic mice will be reduced to less than 3000 times compared with normal mice; the feces of obese mice In Ekman mucinophilus, it will be reduced to less than 100 times compared with normal mice. The growth of Ekman Muxophilus in the intestines of mice on a high-fat diet can protect mice from the metabolic and immune risks caused by high-fat diets. It has a very significant effect on increasing the effect of cancer immunotherapy. Therefore, providing a proper diet to increase the number of Ekmanmucinophilus in the gastrointestinal tract is expected to be beneficial in maintaining physical health.

先前研究指出直接於膳食中添加Bifidobacterium animalis subsp.lactis菌種提供小鼠連續食用14天,可增加糞便中艾克曼嗜黏蛋白菌的數量,但是Lactobacillus rhamnosus則無此效果;此外,提供果寡糖給接受高脂飲食的小鼠,可有效提昇糞便中艾克曼嗜黏蛋白菌的數量;補充蔓越莓或康考特葡萄萃取物,可以有效提昇糞便中艾克曼嗜黏蛋白菌的數量,然而補充石榴萃取物、綠茶萃取物或加州葡萄萃取物,對於健康人或小鼠的艾克曼嗜黏蛋白菌的數量變化沒有影響。 Previous studies have shown that adding Bifidobacterium animalis subsp.lactis to the diet directly for 14 days can increase the number of Ekmanmucinophilus in the feces, but Lactobacillus rhamnosus has no such effect; Sugar given to mice receiving a high-fat diet can effectively increase the number of Ekman Mucophila in the feces; supplementation with cranberry or Concord grape extract can effectively increase the amount of Ekman Mucophila in the feces. Quantity, however, supplementation with pomegranate extract, green tea extract, or California grape extract had no effect on changes in the number of Ekmanmucinophilus in healthy humans or mice.

目前對於為何透過特定的膳食補充可以提昇動物體內的艾克曼嗜黏蛋白菌數量機制尚未了解,因此,對於何種益生菌、或是何種組合的益生菌,在何種的基質下進行發酵後的產物,對於提昇動物體內艾克曼嗜黏蛋白菌數量,仍需進行探討。 At present, the mechanism of why the number of Ekmanmucinophilus in animals can be increased by specific dietary supplements is not known. Therefore, what kind of probiotics, or what kind of combination of probiotics, and under what kind of substrate are fermented The latter product still needs to be explored to increase the number of Ekman Muxophilus in animals.

有鑑於此,如何於提供一種可以提昇動物體內或是體外艾克曼嗜黏蛋白菌數量的植物性發酵產物及其應用,即成為本發明在此欲解決的一重要課題。 In view of this, how to provide a plant-based fermentation product that can increase the number of Ekmanyl muxophilus in animals or in vitro and its application has become an important issue to be solved by the present invention.

本發明的目的即在於提供一種新穎乳酸菌株,該菌為一種植物乳桿菌(Lactobacillus plantarum),其係寄存於中華民國食品工業發展研究所,寄存編號為BCRC910891,及寄存於中國微生物菌種保藏管理委員會普通微生物中心,寄存編號為CGMCC17716。 The object of the present invention is to provide a novel lactic acid strain, which is a Lactobacillus plantarum , which is deposited in the Food Industry Development Research Institute of the Republic of China, and the deposit number is BCRC910891, and is deposited in the China Microorganism Culture Collection Management Committee General Microbiology Center, deposit number CGMCC17716.

本發明的另一目的即在於提供一種植物性凝態優格,是以植 物漿加入益生菌製成,其中該益生菌是植物乳桿菌(Lactobacillus plantarum),其係寄存於中華民國食品工業發展研究所,寄存編號為BCRC910891,及寄存於中國微生物菌種保藏管理委員會普通微生物中心,寄存編號為CGMCC17716;其中該植物性凝態優格的離水性小於25%。 Another object of the present invention is to provide a vegetable condensed yogurt, which is prepared by adding probiotics to plant pulp, wherein the probiotics are Lactobacillus plantarum , which is registered in the Food Industry Development Research of the Republic of China Institute, the deposit number is BCRC910891, and the deposit number is CGMCC17716, and the deposit number is CGMCC17716; the water-free water of the plant condensed yogurt is less than 25%.

為達前述發明目的,其中該益生菌可進一步包含戊糖片球菌(Pediococcus pentosaceus)。 In order to achieve the aforementioned purpose of the invention, the probiotics may further comprise Pediococcus pentosaceus .

為達前述發明目的,其中該植物漿是水與五穀雜糧均質化所得。 In order to achieve the aforementioned purpose of the invention, the plant pulp is obtained by homogenizing water and whole grains.

為達前述發明目的,其中該五穀雜糧與核果選自於由小米、大米、麥、大豆、高粱、花生、薏仁、藜麥、薏仁、杏仁、芝麻、紅豆、綠豆、腰果所組成的群組。 For the purpose of the invention, wherein the whole grains and stone fruits are selected from the group consisting of millet, rice, wheat, soybean, sorghum, peanut, coix seed, quinoa, coix seed, almond, sesame, red bean, mung bean, and cashew nut.

為達前述發明目的,每100克該植物性凝態優格中的伽瑪胺基丁酸含量超過15毫克。 In order to achieve the aforementioned purpose of the invention, the content of gamma aminobutyric acid in every 100 grams of the vegetable condensed yogurt exceeds 15 mg.

為達前述發明目的,每100克該植物性凝態優格中的伽瑪胺基丁酸含量超過25毫克。 In order to achieve the aforementioned purpose of the invention, the content of gamma aminobutyric acid in each 100 grams of the vegetable condensed yogurt exceeds 25 mg.

為達前述發明目的,其中該植物性凝態優格中異黃酮的去醣基率超過80%。 In order to achieve the aforementioned purpose of the invention, the deglycosylation rate of isoflavones in the vegetable condensed yogurt exceeds 80%.

為達前述發明目的,其中該植物性凝態優格,可做為培養艾克曼嗜黏蛋白菌(Akkermansia muciniphilia)的培養成分使用。 In order to achieve the aforementioned object of the invention, the vegetable condensed yogurt can be used as a culture component for culturing Akkermansia muciniphilia .

本發明的又一目的即在於提供一種前述植物性凝態優格用於改善腸道菌相的用途。 Another object of the present invention is to provide a use of the aforementioned vegetable condensed yogurt for improving intestinal flora.

為達前述發明目的,其中該改善腸道菌相是改善糖尿病患者 的腸道菌相。 In order to achieve the above-mentioned object of the invention, wherein the improvement of the intestinal flora is to improve the diabetic patients. of gut bacteria.

為達前述發明目的,其中該改善腸道菌相是腸道中有益菌或伺機菌增加。 In order to achieve the aforementioned purpose of the invention, the improvement of the intestinal flora is the increase of beneficial bacteria or opportunistic bacteria in the intestinal tract.

為達前述發明目的,其中該有益菌包括但不限定是艾克曼嗜黏蛋白菌(Akkermansia muciniphilia)。 In order to achieve the aforementioned purpose of the invention, the beneficial bacteria include but are not limited to Akkermansia muciniphilia .

綜上所述,與現有技術相較。本發明由台灣高山茶葉植栽篩選出的植物乳桿菌菌株BCRC 910891具有以下優點: To sum up, compared with the prior art. The present invention has the following advantages:

(1)BCRC 910891具有良好的黏稠性多醣生產能力,單獨使用或搭配其他益生菌都可以使豆類蛋白(豆漿)凝集成為不易離水的植物性凝態優格--豆漿乳酸菌發酵品。 (1) BCRC 910891 has a good production capacity of viscous polysaccharides. It can be used alone or in combination with other probiotics to agglomerate soy protein (soymilk) into a vegetable condensed state yogurt that is not easy to separate from water-soymilk lactic acid bacteria fermentation product.

(2)BCRC 910891製成的豆漿乳酸菌發酵品可以提升腸道中有益菌、伺機菌並有效促進Akkermansia muciniphila菌株在腸道菌群中的比例,可以改善腸道菌相,尤其可以改善糖尿病患者的腸道菌相。 (2) The soymilk lactic acid bacteria fermented product made by BCRC 910891 can improve the beneficial bacteria and opportunistic bacteria in the intestine and effectively promote the ratio of Akkermansia muciniphila strain in the intestinal flora, which can improve the intestinal flora, especially the intestinal flora of diabetic patients. Fungal phase.

(3)BCRC 910891製成的豆漿乳酸菌發酵品中的γ-氨基丁酸含量、去醣基異黃酮佔總異黃酮量大量提升。 (3) The content of γ -aminobutyric acid and the proportion of deglycosyl isoflavones in the total isoflavones in the soymilk lactic acid bacteria fermented products made by BCRC 910891 were greatly increased.

除豆類發酵品外,以BCRC 910891將燕麥、米、薏仁等製成的植物漿乳酸菌發酵品,亦可促進Akkermansia muciniphila菌株生長。 In addition to soy fermented products, lactic acid bacteria fermented products made from oats, rice, and barley with BCRC 910891 can also promote the growth of Akkermansia muciniphila strains.

1係為含有單獨或混合植物乳桿菌L.plantarum BCRC 910891(A)、戊糖片球菌Pediococcus pentosaceus BCRC 11064(B)及戊醣乳酸桿菌Lactobacillus pentosus BCRC 11053(C)的豆漿乳酸菌發酵物,對於艾克曼嗜黏蛋白菌Akkermansia muciniphila BCRC 81048T生長的影響。 Figure 1 shows the lactic acid bacteria fermentation products of soybean milk containing L. plantarum BCRC 910891 (A), Pediococcus pentosaceus BCRC 11064 (B) and Lactobacillus pentosus BCRC 11053 (C) alone or in combination. Effects of Akkermansia muciniphila BCRC 81048 T growth.

2係為含有混合植物乳桿菌L.plantarum BCRC 910891(A)、戊糖片球菌Pediococcus pentosaceus BCRC 11064(B)及戊醣乳酸桿菌Lactobacillus pentosus BCRC 11053(C)以市售不同植物來源為基質發酵的產物,對於艾克曼嗜黏蛋白菌Akkermansia muciniphila BCRC 81048T生長的影響。 Figure 2 shows the fermentation of mixed L. plantarum BCRC 910891 (A), Pediococcus pentosaceus BCRC 11064 (B) and Lactobacillus pentosus BCRC 11053 (C) using commercially available plant sources as substrates The effect of the product on the growth of Akkermansia muciniphila BCRC 81048 T.

3係為STZ成功誘導的糖尿病模式小鼠,分別熟豆漿(比較組)以及L.plantarum BCRC 910891發酵的熟豆漿乳酸菌發酵物(實驗組)餵食28天後的腸道菌相變化。 Figure 3 shows the changes of intestinal flora in the diabetic model mice successfully induced by STZ, respectively, after 28 days of feeding with cooked soy milk (comparison group) and cooked soy milk lactic acid bacteria fermented by L. plantarum BCRC 910891 (experimental group).

4係為STZ成功誘導的糖尿病模式小鼠,分別熟豆漿(比較組)以及L.plantarum BCRC 910891發酵的熟豆漿乳酸菌發酵物(實驗組)餵食28天後的腸道中艾克曼嗜黏蛋白菌所佔的比例。 Figure 4 shows the diabetic model mice successfully induced by STZ. Ekman mucin in the intestines of the cooked soy milk (comparative group) and the cooked soy milk lactic acid bacteria fermented by L. plantarum BCRC 910891 (experimental group) were fed for 28 days. proportion of bacteria.

本發明係以下面的實施例予以示範闡明,但本發明不受下述實施例所限制。 The present invention is exemplified by the following examples, but the present invention is not limited by the following examples.

微生物及培養基:本實驗特有的植物乳桿菌L.plantarum BIFT-LP-588,為自台灣高山茶葉植栽篩選出的菌株,寄存於財團法人食品工業發展研究所,寄存日期為2019年5月3日、寄存編號為BCRC 910891;且依據布達佩斯條約,寄存於中國微生物菌種保藏管理委員會普通微生物中心、寄存日期為2019年5月6日、寄存編號為CGMCC17716。其他使用乳酸菌購自台灣食品工業研究所生物資源保存及研究中心(BCRC),包括植物乳桿菌L.plantarum BCRC 10069、戊糖片球菌Pediococcus pentosaceus BCRC 11064、戊醣乳酸桿菌Lactobacillus pentosus BCRC 11053。以上乳酸 菌的冷凍菌液1mL加入50mL的MRS培養液,以37℃培養8-24小時,使菌液活化,使菌數達到1.0* 108CFU/mL。 Microorganisms and culture medium: L. plantarum BIFT -LP-588, which is unique to this experiment, is a strain selected from Taiwan's alpine tea planting and is deposited in the Food Industry Development Research Institute, a consortium, and the deposit date is May 3, 2019 The date, the deposit number is BCRC 910891; and in accordance with the Budapest Treaty, the deposit date is May 6, 2019, and the deposit number is CGMCC17716. Other used lactic acid bacteria were purchased from the Biological Resource Conservation and Research Center (BCRC), Taiwan Institute of Food Industry, including L. plantarum BCRC 10069, Pediococcus pentosaceus BCRC 11064, and Lactobacillus pentosus BCRC 11053 . Add 50 mL of MRS culture solution to 1 mL of the above frozen bacterial solution of lactic acid bacteria, and cultivate at 37° C. for 8-24 hours to activate the bacterial solution, so that the number of bacteria reaches 1.0*10 8 CFU/mL.

實施例1 植物性凝態優格之製造方法 Embodiment 1 The manufacturing method of vegetable condensed state yogurt

提供一植物蛋白混合物,其中該植物蛋白混合物是由五穀雜糧或核果及水所組成;進行一均質化步驟及一加熱步驟,使該植物蛋白混合物形成一植物漿,其中該加熱步驟係在高於90℃進行;以及進行一醱酵步驟,該植物漿中加入一醱酵菌種,在一醱酵溫度下進行一醱酵時間,使該植物蛋白混漿之pH值達4.5時隨即於4℃進行低溫處理,藉此使該植物漿形成該植物性凝態優格;其中該五穀雜糧與核果包含小米、大米、麥、大豆、高粱、花生、薏仁、藜麥、薏仁、杏仁、芝麻、紅豆、綠豆、腰果,該植物乳桿菌(Lactobacillus plantarum)寄存於中華民國食品工業發展研究所,寄存編號為BCRC910891,及寄存於中國微生物菌種保藏管理委員會普通微生物中心,該醱酵時間是6-36小時,該醱酵溫度是27-45℃。 A vegetable protein mixture is provided, wherein the vegetable protein mixture is composed of whole grains or stone fruits and water; a homogenization step and a heating step are performed to make the vegetable protein mixture form a vegetable pulp, wherein the heating step is higher than 90 ℃; And carry out a fermenting step, add a fermenting strain to the vegetable pulp, and carry out a fermenting time at a fermenting temperature, when the pH value of the vegetable protein mixed pulp reaches 4.5, immediately at 4 ℃ Carry out low temperature treatment, whereby the vegetable pulp is formed into the vegetable condensed state yogurt; wherein the whole grains and stone fruits comprise millet, rice, wheat, soybean, sorghum, peanut, barley, quinoa, barley, almond, sesame, red bean , mung beans, cashew nuts, the Lactobacillus plantarum is deposited in the Food Industry Development Research Institute of the Republic of China, and the deposit number is BCRC910891, and is deposited in the General Microorganism Center of the China Microbial Culture Collection and Management Committee, and the fermentation time is 6-36 hours, the fermentation temperature was 27-45°C.

前述方法製得植物性凝態優格的離水性小於25%,具有良好口感,且每100克該植物性凝態優格中的伽瑪胺基丁酸含量超過15毫克、異黃酮的去醣基率超過80%,營養價值高。 The vegetal condensed state yogurt obtained by the aforementioned method has a water separation of less than 25%, has a good taste, and the gamma aminobutyric acid content per 100 grams of the vegetable condensed state yogurt exceeds 15 mg, and the isoflavones are desugarized. The base rate is more than 80%, and the nutritional value is high.

實施例2 植物乳桿菌(L.plantarum)BCRC 910891特性 Example 2 Characteristics of L. plantarum BCRC 910891

本實驗特有的植物乳桿菌(L.plantarum)BCRC 910891,自台灣高山茶葉植栽篩選出植物乳桿菌L.plantarum BCRC 910891。經分子生物學鑑定16rDNA序列如附件。與目前公開的植物乳桿菌的16S ribosomal RNA部分序列相似度未達100%,分別如下;Lactobacillus plantarum strain JCM 1149 16S ribosomal RNA(99.60598897%)、Lactobacillus plantarum strain NBRC 15891 16S ribosomal RNA(99.52718676%)、Lactobacillus plantarum strain CIP 103151 16S ribosomal RNA、(99.52718676%)、Lactobacillus plantarum strain JCM 1149 16S ribosomal RNA(99.52718676%)、Lactobacillus plantarum strain NRRL B-14768 16S ribosomal RNA(99.52718676%)、Lactobacillus plantarum strain NBRC 15891 16S ribosomal RNA(99.52038369%)、及Lactobacillus plantarum subsp.argentoratensis strain DKO 22 16S ribosomal RNA(98.81982691%)等。 L. plantarum BCRC 910891 , which is unique to this experiment, was screened out from Taiwan alpine tea plants. The 16rDNA sequence was identified by molecular biology as appendix. The partial sequence similarity with the 16S ribosomal RNA of Lactobacillus plantarum disclosed so far is less than 100%, as follows ; plantarum strain CIP 103151 16S ribosomal RNA、(99.52718676%)、 Lactobacillus plantarum strain JCM 1149 16S ribosomal RNA(99.52718676%)、 Lactobacillus plantarum strain NRRL B-14768 16S ribosomal RNA(99.52718676%)、 Lactobacillus plantarum strain NBRC 15891 16S ribosomal RNA( 99.52038369%), and Lactobacillus plantarum subsp. argentoratensis strain DKO 22 16S ribosomal RNA (98.81982691%) and so on.

實施例3 益生菌產生多醣能力的差異 Example 3 Differences in the ability of probiotics to produce polysaccharides

1結果顯示益生菌產生多醣能力的差異,植物乳桿菌L.plantarum BCRC 910891於MRS培養基中,培養24小時,以苯酚硫酸法分析多醣含量,可得7380ppm,相較於植物乳桿菌(L.plantarum)BCRC 10069於同樣培養條件下,所生產的3222ppm的多醣為高;相較於其他不同來源篩選到的植物乳桿菌,於相同培養條件下所得到的多醣也相對高。 The results in Table 1 show the difference in the ability of probiotics to produce polysaccharides. Lactobacillus plantarum BCRC 910891 was cultured in MRS medium for 24 hours, and the polysaccharide content was analyzed by the phenol sulfuric acid method . plantarum ) BCRC 10069 under the same culture conditions, the polysaccharide produced at 3222ppm is high; compared with other Lactobacillus plantarum screened from different sources, the polysaccharides obtained under the same culture conditions are also relatively high.

Figure 108131848-A0101-12-0010-1
Figure 108131848-A0101-12-0010-1

植物乳桿菌(L.plantarum)BCRC 910891於MRS平板培養基 中,培養24小時後,以牙籤垂直勾取菌落,丈量菌落黏絲延展長度可達300mm,相較於L.plantarum BCRC 10069於同樣培養條件下,菌落黏絲延展長度為120mm;其他不同來源篩選到的植物乳桿菌,於相同培養條件下,丈量菌落黏絲延展長度為0-210mm不等,而其他的乳酸菌如鼠李糖乳桿菌(Lactobacillus rhamnosus TS6)、短乳桿菌(Lactobacillus brevis BCRC 12310)、戊糖片球菌Pediococcus pentosaceus BCRC 11064,於相同培養條件下,丈量菌落黏絲延展長度為0-95mm不等。 L. plantarum BCRC 910891 was cultured in MRS plate medium for 24 hours. After 24 hours, the colonies were picked vertically with a toothpick . Under the same culture conditions, the length of the colony sticky filaments was 120 mm; for Lactobacillus plantarum screened from different sources, under the same culture conditions, the measured colony sticky filaments extended lengths ranging from 0 to 210 mm, while other lactic acid bacteria such as Lactobacillus rhamnosus (Lactobacillus rhamnosus ( Lactobacillus rhamnosus TS6), Lactobacillus brevis BCRC 12310, Pediococcus pentosaceus BCRC 11064, under the same culture conditions, the measured length of colony sticky filaments ranged from 0 to 95 mm.

植物乳桿菌L.plantarum BCRC 910891於MRS培養基中所產出的多醣量相較於L.plantarum G30或P30的多醣含量為低,但是植物乳桿菌L.plantarum BCRC 910891所呈現的多醣延展特性遠較L.plantarum G30或P30為佳,顯示不同的植物乳桿菌仍有在多醣特性上的差異,而且多醣含量與多醣延展特性,並不一定有正相關關係。 The amount of polysaccharide produced by L. plantarum BCRC 910891 in MRS medium is lower than that of L. plantarum G30 or P30, but the polysaccharide ductility exhibited by L. plantarum BCRC 910891 is much higher than that of L. plantarum G30 or P30. L. plantarum G30 or P30 is better, showing that different Lactobacillus plantarum still have differences in polysaccharide properties, and there is not necessarily a positive correlation between polysaccharide content and polysaccharide extension properties.

實施例4 乳酸菌發酵品 Example 4 Lactic acid bacteria fermented product

4-1 乳酸菌發酵品製備 4-1 Preparation of lactic acid bacteria fermentation products

豆漿製作:豆漿包含熟豆漿與熟全豆豆漿;熟豆漿製作:黃豆浸泡於水中1:5的比例後,利用市售研磨設備,將黃豆磨漿均質化後,使用市售之過濾設備、濾布或濾網等去除豆渣後,所得的生豆漿,放入高壓滅菌釜,進行階段性熱處理:以105℃加熱5分鐘,將大豆之脂肪氧化酵素的活性去除,溫度降至90℃加熱15分鐘。待熟豆漿冷卻後,置入4℃備用;熟全豆豆漿製作:黃豆浸泡於水中1:5的比例後,過濾,將過濾後的水秤重後記錄,將瀝乾的黃豆置入放入高壓滅菌釜,進行階段性熱處理:以121℃加熱10分鐘,溫度降至105℃加熱25-60分鐘後,取出後置於市售濕式均質 機,如果汁機等,並加入加熱前紀錄的過濾後水重後,進行均質。將均質後全豆豆漿於90℃加熱15分鐘,待全豆豆漿冷卻後,置入4℃備用。 Soymilk production: Soymilk includes cooked soybean milk and cooked whole soybean milk; Cooked soybean milk production: After soaking soybeans in water at a ratio of 1:5, use commercially available grinding equipment to homogenize the soybean pulp, then use commercially available filtering equipment, filter After removing the soybean dregs with cloth or filter, the obtained raw soybean milk is put into an autoclave for staged heat treatment: heated at 105°C for 5 minutes to remove the activity of soybean lipoxygenase, and the temperature is lowered to 90°C and heated for 15 minutes . After the cooked soy milk is cooled, put it at 4°C for later use; for the production of cooked whole soy milk: soak the soybeans in water at a ratio of 1:5, filter, weigh the filtered water and record it, put the drained soybeans in the Autoclave for staged heat treatment: heat at 121°C for 10 minutes, reduce the temperature to 105°C and heat for 25-60 minutes, take it out and place it in a commercially available wet homogenizer machine, such as a juicer, etc., and add the filtered water weight recorded before heating, and then homogenize. The homogenized whole soybean milk was heated at 90°C for 15 minutes, and after the whole soybean milk was cooled, it was placed at 4°C for use.

豆漿乳酸菌發酵:將冷藏的熟豆漿或全豆豆漿先於65℃加熱30分鐘,使其溫度降溫度至37℃以下,即可作為乳酸菌發酵用基質。取0.1-5%(v/v)之活化乳酸菌菌液加入發酵基質中,使各乳酸菌菌種於發酵基質中的起始菌數為每毫升至少有1.0*105CFU,於30-37℃培養8-24小時,當豆漿乳酸菌發酵品的pH值達4.6時,即達發酵終點,移入4℃進行低溫熟成處理。將發酵品以冷凍乾燥機進行冷凍乾燥後,再以均質機打碎成粉末,得到粉狀的豆漿乳酸菌發酵品,再以無菌水還原為豆漿乳酸菌發酵品溶液。 Soymilk lactic acid bacteria fermentation: The refrigerated cooked soybean milk or whole soybean milk is heated at 65°C for 30 minutes, and the temperature is lowered to below 37°C, which can be used as the substrate for lactic acid bacteria fermentation. Add 0.1-5% (v/v) of activated lactic acid bacteria liquid to the fermentation substrate, so that the initial bacterial count of each lactic acid bacteria strain in the fermentation substrate is at least 1.0*10 5 CFU per milliliter, at 30-37 ℃ After culturing for 8-24 hours, when the pH value of the soymilk lactic acid bacteria fermented product reaches 4.6, the fermentation end point is reached, and it is moved to 4°C for low-temperature aging treatment. The fermented product is freeze-dried with a freeze dryer, and then crushed into powder with a homogenizer to obtain a powdered soymilk lactic acid bacteria fermented product, which is then reduced to a soymilk lactic acid bacteria fermented product solution with sterile water.

植物漿乳酸菌發酵:購買市售薏仁漿、杏仁漿、米漿、黎麥漿,加入植物乳桿菌L.plantarum BCRC 910891、L.plantarum BCRC 10069T、戊糖片球菌Pediococcus pentosaceus BCRC 11064及戊醣乳酸桿菌Lactobacillus pentosus BCRC 11053T各1%,於30-37℃培養8-24小時,當植物漿乳酸菌發酵品的pH值達4.6時,即達發酵終點,移入4℃進行低溫熟成處理。將發酵品以冷凍乾燥機進行冷凍乾燥後,再以均質機打碎成粉末,得到粉狀的植物漿乳酸菌發酵品,再以無菌水還原為植物漿乳酸菌發酵品溶液。 Lactobacillus fermentation of plant pulp: buy commercially available coix seed pulp, almond milk, rice milk, and wheat milk, add L. plantarum BCRC 910891 , L. plantarum BCRC 10069 T , Pediococcus pentosaceus BCRC 11064 and pentose lactic acid Bacillus Lactobacillus pentosus BCRC 11053 T was 1% each, and cultured at 30-37°C for 8-24 hours. When the pH value of the fermented product of Lactobacillus pentosus in plant plasma reached 4.6, the fermentation end point was reached, and it was transferred to 4°C for low-temperature aging treatment. After the fermented product is freeze-dried with a freeze dryer, it is crushed into powder with a homogenizer to obtain a powdered lactic acid bacteria fermentation product, which is then reduced to a solution of the lactic acid bacteria fermentation product with sterile water.

前述低溫熟成處理的乳酸菌發酵品以冷凍乾燥機進行冷凍乾燥後,再以均質機打碎成粉末,得到粉狀的乳酸菌發酵品,再以無菌水還原為乳酸菌發酵品溶液。 The lactic acid bacteria fermented product of the aforementioned low-temperature aging treatment is freeze-dried with a freeze dryer, and then crushed into powder with a homogenizer to obtain a powdered lactic acid bacteria fermented product, which is then reduced to a lactic acid bacteria fermented product solution with sterile water.

4-2 豆漿乳酸菌發酵品品質檢測 4-2 Quality inspection of soymilk lactic acid bacteria fermentation products

豆漿乳酸菌發酵品特性 Characteristics of soymilk lactic acid bacteria fermentation products

以不同益生菌完成的熟豆漿乳酸菌發酵品與熟全豆豆漿乳酸菌發酵品冷藏於4℃,定期取出測定乳酸菌菌數、酸度(相對乳酸含量)、離水量等特性,評估豆漿乳酸菌發酵品特性,結果如表2所示。 The cooked soybean milk lactic acid bacteria fermented products and the cooked whole soybean soybean milk lactic acid bacteria fermented products completed with different probiotics were refrigerated at 4 °C, and the characteristics of the lactic acid bacteria bacteria count, acidity (relative lactic acid content), and water separation were measured regularly, and the characteristics of the soybean milk lactic acid bacteria fermented products were evaluated. The results are shown in Table 2 .

Figure 108131848-A0101-12-0013-2
Figure 108131848-A0101-12-0013-2
Figure 108131848-A0101-12-0014-4
Figure 108131848-A0101-12-0014-4

離水率檢測 Water separation rate detection

取20克樣品以1000 xg離心10分鐘,倒出上清液並秤重。豆漿乳酸菌發酵品於保存期間,由於乳酸菌仍持續產酸,使得蛋白質凝結的結構不斷改變,將結構中的水分釋出,而造成離水現象(syneresis)。此現象的產生過多,會造成整體組織與品質的不一致,對於產品口感會有所影響,因此離水程度越少越好。離水程度計算方式如下:離水程度=上清液重量/大豆乳酸菌發酵品原重(20g)x 100% A 20 g sample was centrifuged at 1000 x g for 10 min, the supernatant was decanted and weighed. During the storage period of soymilk lactic acid bacteria fermented products, because the lactic acid bacteria continue to produce acid, the structure of protein coagulation is constantly changed, and the water in the structure is released, resulting in syneresis. Excessive occurrence of this phenomenon will cause inconsistencies in the overall organization and quality, which will affect the taste of the product, so the less water separation, the better. The calculation method of the degree of water separation is as follows: degree of water separation = weight of supernatant / original weight of soybean lactic acid bacteria fermentation product (20g) x 100%

所有組合,於發酵24小時內,均可達到108CFU/mL以上的乳酸菌濃度。相較無添加植物乳桿菌L.plantarum BCRC 910891的組合,添加有植物乳桿菌L.plantarum BCRC 910891的組合中,發酵終點的pH略高,且於4℃冷藏後7天pH值下降幅度亦較小,也有較低的離水率。單獨以植物乳桿菌L.plantarum BCRC 910891進行豆漿發酵,發酵24小時候,pH仍在4.5以上,呈現具半流動性的凝結狀,因此未進行離水率的測試。 All combinations can reach the concentration of lactic acid bacteria above 10 8 CFU/mL within 24 hours of fermentation. Compared with the combination without L. plantarum BCRC 910891 , in the combination with L. plantarum BCRC 910891 , the pH at the end of fermentation was slightly higher, and the pH value decreased more than 7 days after refrigerating at 4°C. Small, but also has a lower water separation rate. Soymilk was fermented with L. plantarum BCRC 910891 alone. After 24 hours of fermentation, the pH was still above 4.5, showing a semi-fluid coagulation shape, so the water separation rate was not tested.

4-3 伽瑪胺基丁酸(γ-aminobutyric acid;GABA)分析 Analysis of 4-3 gamma aminobutyric acid (γ-aminobutyric acid; GABA)

GABA在中樞神經系統中為一個主要抑制神經傳導的物質,近年來透過研究已證實GABA不論以注射或口服的方式,均可透過生理機制對血壓上升、提升睡眠品質及改善情緒沮喪的現象達到控制的目的。「日本健康營養食品協會」,已明確認定GABA為「特定保健用食品」中,對於高血壓患者推薦使用的素材之一,此型態的食品中,GABA每日建議攝取10-20mg即具有降血壓功能;而「日本機能性食品研究會」推薦認為 GABA為具有成為機能性素材的潛力,許多研究已指出攝取GABA 26.4mg具有改善失眠及焦慮的效果。本研究使用不同乳酸菌加入豆漿中進行發酵,結果整理於表2:單獨使用L.plantarum BCRC 910891,可使豆漿中的GABA含量自9.36±0.06mg/100g大幅提升至25.97±0.08mg/100g;加入乳酸菌包括L.plantarum BCRC 910891、L.plantarum BCRC 10069TL.plantarum G30、Pediococcus pentosaceus BCRC 11064以及Lactobacillus pentosus BCRC 11053T等於豆漿中發酵,則使發酵品中的GABA可提升至35.72±0.15mg/100g;若加入L.plantarum BCRC 910891、Pediococcus pentosaceus BCRC 11064以及Lactobacillus pentosus BCRC 11053T則發酵品中的GABA含量為26.34±0.13mg/100g;若上述的乳酸菌組合中,植物乳桿菌僅使用plantarum BCRC 10069以及自行篩選的植物乳桿菌L.plantarum G30搭配Pediococcus pentosaceus BCRC 11064以及Lactobacillus pentosus BCRC 11053T則發酵品中的GABA含量為20.46±0.07mg/100g;由實驗結果顯示植物乳桿菌L.plantarumPediococcus pentosaceus以及Lactobacillus pentosus在發酵豆漿的過程中,乳酸菌之間的彼此交互作用,也可以使發酵結果中的GABA含量提升;另一方面也發現,不同的植物乳桿菌在豆漿中發酵時,對於提升發酵豆漿的GABA含量,有所不同,在本研究中顯示,L.plantarum BCRC 10069T或自行篩選的植物乳桿菌L.plantarum G30亦會生產GABA,但仍以植物乳桿菌L.plantarum BCRC910891的生產能力較佳。 GABA is a substance that mainly inhibits nerve conduction in the central nervous system. In recent years, studies have confirmed that GABA, whether by injection or oral administration, can control the phenomenon of blood pressure increase, sleep quality and emotional depression through physiological mechanisms. the goal of. The "Japan Health and Nutritional Foods Association" has clearly identified GABA as one of the materials recommended for use in "special health food" for hypertensive patients. In this type of food, the recommended daily intake of 10-20mg of GABA has the effect of reducing blood pressure. Blood pressure function; and the "Japan Functional Food Research Association" recommends that GABA has the potential to become a functional material. Many studies have pointed out that ingesting GABA 26.4mg has the effect of improving insomnia and anxiety. In this study, different lactic acid bacteria were added to soy milk for fermentation, and the results are summarized in Table 2: L. plantarum BCRC 910891 alone can significantly increase the GABA content in soy milk from 9.36±0.06mg/100g to 25.97±0.08mg/100g; adding Lactic acid bacteria including L.plantarum BCRC 910891, L.plantarum BCRC 10069 T , L.plantarum G30, Pediococcus pentosaceus BCRC 11064 and Lactobacillus pentosus BCRC 11053 T are fermented in soybean milk, so the GABA in the fermented product can be increased to 35.72±0.15mg/ 100g; if L.plantarum BCRC 910891, Pediococcus pentosaceus BCRC 11064 and Lactobacillus pentosus BCRC 11053 T are added, the GABA content in the fermented product is 26.34±0.13mg/100g; if the above lactic acid bacteria combination, Lactobacillus plantarum only uses plantarum BCRC 10069 And the self-screened L. plantarum G30 combined with Pediococcus pentosaceus BCRC 11064 and Lactobacillus pentosus BCRC 11053 T , the GABA content in the fermented product was 20.46±0.07mg/100g; the experimental results showed that L. plantarum and Pediococcus pentosaceus And Lactobacillus pentosus in the process of fermenting soybean milk, the interaction between lactic acid bacteria can also increase the GABA content in the fermentation result; In this study, L. plantarum BCRC 10069 T or self-selected L. plantarum G30 can also produce GABA, but the production capacity of L. plantarum BCRC910891 is still higher than that of L. plantarum BCRC910891 . good.

4-4 異黃酮(Isoflavones)去醣基分析 4-4 Isoflavones (Isoflavones) Deglycosylation Analysis

大豆異黃酮為大豆中含有的一種植物性雌激素(phytoestrogens),已有需多科學文獻指出大豆異黃酮對於乳癌、直腸癌、或 是骨質疏鬆有預防的效果,長期食用含有大豆異黃酮的食品,對於更年期症候群的症狀有減緩的現象。大豆異黃酮中,有許多結構相近的化合物,大致可以大豆異黃酮苷素(daidzein)、金雀異黃酮苷素(genistein)、黃豆黃苷素(glycitein)等三群去醣基異黃酮(aglycones)為主結構,再連接上不同糖基,而形成大豆異黃酮苷(daidzin)、金雀異黃酮苷(genistin)、黃豆黃苷(glycitin)、大豆異黃酮苷素(daidzein)、金雀異黃酮苷素(genistein)、黃豆黃苷素(glycitein)、乙醯大豆異黃酮苷(acetyldaidzin)、乙醯金雀異黃酮苷(acetylgenistin)、乙醯黃豆黃苷(acetylglycitin)、丙二醯大豆異黃酮苷(malonyldaidzin)、丙二醯金雀異黃酮苷(malonylgenistin)及丙二醯黃豆黃苷(malonylglycitin)等帶醣基異黃酮安定存在於黃豆中。黃豆將攝食後,透過腸內微生物所生產的糖基水解酵素(glycosidases)水解成去醣基異黃酮,這些去醣基異黃酮可在體內進一步代謝形成equol等化合物;由於這些代謝物的化學結構與哺乳類動物的雌激素(estrogen)非常相似,因此能在體內表現出「選擇性雌激素接受調節器(S.E.R.M.)」的特性。 Soy isoflavones are a kind of phytoestrogens contained in soybeans, and more scientific literatures have pointed out that soy isoflavones are effective in breast cancer, rectal cancer, or It has a preventive effect on osteoporosis. Long-term consumption of foods containing soy isoflavones can alleviate the symptoms of menopausal syndrome. In soy isoflavones, there are many compounds with similar structures, which can be roughly divided into three groups of aglycones, such as daidzein, genistein, and glycitein. The main structure is connected with different sugar groups to form daidzin, genistin, glycitin, daidzein, genistein genistein, glycitein, acetyldaidzin, acetylgenistin, acetylglycitin, malonyldaidzin ), malonylgenistin and malonylglycitin and other glycosyl isoflavones are stable in soybean. After ingestion, soybeans are hydrolyzed into deglycosyl isoflavones by glycosidases produced by intestinal microorganisms. These deglycosyl isoflavones can be further metabolized in the body to form compounds such as equol; due to the chemical structure of these metabolites It is very similar to estrogen in mammals, so it can exhibit the properties of "Selective Estrogen Receptor Modulator (S.E.R.M.)" in the body.

然而,由於在人體腸道中所分布的微生物,不一定都具有良好的醣基水解酵素,因此可能影響大豆異黃酮的生物活性利用率。因此透過加工的製程,挑選適當的微生物對於大豆中的帶醣基異黃酮進行轉換,可有效提供具有生理活性的去醣基異黃酮的發酵食品。 However, because the microorganisms distributed in the human intestinal tract do not necessarily have good glycosyl hydrolysis enzymes, it may affect the bioactive utilization of soybean isoflavones. Therefore, through the processing process, selecting appropriate microorganisms to convert the glycosyl isoflavones in soybeans can effectively provide fermented foods with deglycosylated isoflavones with physiological activity.

本研究中所使用的植物乳桿菌L.plantarum BCRC910891具有優秀的醣基水解酵素生產能力,單獨使用時,可使豆漿中的去醣基異黃酮比例達88.62±0.13%;L.plantarum BCRC 10069T,可使豆漿中的去醣基異黃酮比例達61.62±0.13%,但自行篩選的L.plantarum G30,僅豆漿中的去醣 基異黃酮比例達24.32±0.06%,戊糖片球菌Pediococcus pentosaceus BCRC 11064或戊醣乳酸桿菌Lactobacillus pentosus BCRC 11053T等,雖可使豆漿中的去醣基異黃酮比例達50.62±0.13%,但若與植物乳桿菌L.plantarum BCRC910891組合,則可使豆漿中的去醣基異黃酮比例達92.15±0.23%。 The L. plantarum BCRC910891 used in this study has excellent production capacity of glycosyl hydrolase. When used alone, the proportion of deglycosylated isoflavones in soy milk can reach 88.62±0.13%; L.plantarum BCRC 10069 T , the proportion of deglycosylated isoflavones in soy milk can reach 61.62±0.13%, but the self-selected L. plantarum G 30 only has deglycosylated isoflavones in soymilk ratio of 24.32±0.06%, Pediococcus pentosaceus Although BCRC 11064 or Lactobacillus pentosus BCRC 11053 T , etc., can make the ratio of deglycosylated isoflavones in soymilk reach 50.62±0.13%, but if combined with L. plantarum BCRC910891 , it can make soymilk deglycosylated isoflavones The proportion of deglycosylated isoflavones was 92.15±0.23%.

實施例5 發酵品對於艾克曼嗜黏蛋白菌生長的影響 The effect of embodiment 5 fermentation product on the growth of Ekman Mucophilus

發酵品前處理:熟豆漿、熟全豆豆漿或植物漿等乳酸菌發酵品進行均質後,於65℃水浴30分鐘後,離心得上清液,將上清液儲存於4℃備用。 Pretreatment of fermented products: After homogenization of lactic acid bacteria fermented products such as cooked soybean milk, cooked whole soybean soybean milk or plant pulp, the supernatant was obtained by centrifugation in a water bath at 65°C for 30 minutes, and the supernatant was stored at 4°C for later use.

艾克曼嗜黏蛋白菌(Akkermansia muciniphila)BCRC 81048T(購自BCRC),培養於GAM培養基,37℃,以N2:CO2(80:20 ratio)置換空氣的絕對厭氧培養箱中培養24小時,使600nm下的吸光值達2.0時離心,去除培養液,蒐集菌體,加入新鮮配置的GAM培養基,調整吸光值至0.05。取經前處理後的發酵品上清液10%(v/v),加入後,37℃,以N2:CO2(80:20 ratio)置換空氣的絕對厭氧培養箱中,培養24小時,以吸光值變化進行艾克曼嗜黏蛋白菌的生長檢測。 Akkermansia muciniphila BCRC 81048 T (purchased from BCRC), cultured in GAM medium, 37°C, in an absolute anaerobic incubator with N 2 : CO 2 (80:20 ratio) replacing air For 24 hours, centrifuge when the absorbance at 600 nm reaches 2.0, remove the culture medium, collect the cells, add freshly prepared GAM medium, and adjust the absorbance to 0.05. Take 10% (v/v) of the supernatant of the pretreated fermentation product, add it, and incubate it in an absolute anaerobic incubator with N 2 : CO 2 (80:20 ratio) at 37°C for 24 hours. The growth of Ekman Muxophila was detected by the change of absorbance value.

相對生長量計算=24小時吸光值-0小時吸光值/0小時吸光值 Calculation of relative growth amount = absorbance value at 24 hours - absorbance value at 0 hours / absorbance value at 0 hours

GAM培養基配方為每公升含有:Proteose Peptone 5.0g、Digested Serum 10.0g、Yeast Extract 2.5g、Meat Extract2.2g、Liver Extract 1.2g、Dextrose 0.5g、Soluble Starch 5.0g、L-Tryptophan 0.2g、L-Cysteine Hydrochloride 0.3g、Sodium Thioglycollate 0.3g、L-Arginine 1.0g、Vitamin K1 5mg、Hemin 10mg、Potassium Dihydrogen Phosphate 2.5g、Sodium Chloride 3.0g、Peptone 5.0g、Soya Peptone 3.0g,調整pH值為7.1。 GAM Medium is formulated to contain per liter: Proteose Peptone 5.0g, Digested Serum 10.0g, Yeast Extract 2.5g, Meat Extract 2.2g, Liver Extract 1.2g, Dextrose 0.5g, Soluble Starch 5.0g, L-Tryptophan 0.2g, L-Tryptophan Cysteine Hydrochloride 0.3g, Sodium Thioglycollate 0.3g, L-Arginine 1.0g, Vitamin K1 5mg, Hemin 10mg, Potassium Dihydrogen Phosphate 2.5g, Sodium Chloride 3.0g, Peptone 5.0g, Soya Peptone 3.0g, pH adjusted to 7.1.

植物乳桿菌L.plantarum BCRC 910891與戊糖片球菌Pediococcus pentosaceus BCRC 11064或戊醣乳酸桿菌Lactobacillus pentosus BCRC 11053T以不同組合,分別添加入熟豆漿中進行發酵,於發酵終點後,經高速離心取得上清液,以10%比例加入GAM培養基中,觀察各種乳酸菌組合的熟豆漿乳酸菌發酵品對艾克曼嗜黏蛋白菌Akkermansia muciniphila BCRC 81048T生長的影響。 L. plantarum BCRC 910891, Pediococcus pentosaceus BCRC 11064 or Lactobacillus pentosus BCRC 11053 T in different combinations were added to cooked soybean milk for fermentation. The supernatant was added to GAM medium at a ratio of 10% to observe the effect of various lactic acid bacteria combinations on the growth of Akkermansia muciniphila BCRC 81048 T.

1結果顯示含有單獨或混合植物乳桿菌BCRC 910891(A)、戊糖片球菌BCRC 11064(B)及戊醣乳酸桿菌BCRC 11053(C)的豆漿乳酸菌發酵物,對於艾克曼嗜黏蛋白菌BCRC 81048T生長的影響。由圖1結果可得知,未經乳酸菌發酵過的豆漿的成分對於艾克曼嗜黏蛋白菌BCRC 81048T的生長刺激,助益非常低。但是經過植物乳桿菌BCRC 910891與戊糖片球菌BCRC 11064或戊醣乳酸桿菌BCRC 11053T以不同組合發酵後的豆漿發酵物,對於艾克曼嗜黏蛋白菌BCRC 81048T的生長,均較原GAM培養基為佳。 Fig. 1 The results show that the fermentation of soymilk lactic acid bacteria containing Lactobacillus plantarum BCRC 910891 (A), Pediococcus pentosaceus BCRC 11064 (B) and Lactobacillus pentosaceus BCRC 11053 (C) alone or in combination, for Ekman Muxophilus Effects of BCRC 81048 T growth. It can be seen from the results in Figure 1 that the components of the soymilk that have not been fermented by lactic acid bacteria have very little effect on the growth stimulation of Ekman Mucophilus BCRC 81048 T. However, the soymilk fermented products fermented with different combinations of Lactobacillus plantarum BCRC 910891 and Pediococcus pentosaceus BCRC 11064 or Lactobacillus pentosus BCRC 11053 T , the growth of Ekman Muxophilus BCRC 81048 T was higher than that of the original GAM. The medium is better.

植物乳桿菌BCRC 910891與戊糖片球菌BCRC 11064及戊醣乳酸桿菌BCRC 11053T共同添加於市售不同植物來源的基質中進行發酵,於發酵終點後,經高速離心取得上清液,以10%比例加入GAM培養基中,觀察各種乳酸菌組合的植物漿乳酸菌發酵品對艾克曼嗜黏蛋白菌BCRC 81048T生長的影響。 Lactobacillus plantarum BCRC 910891, Pediococcus pentosus BCRC 11064 and Lactobacillus pentosus BCRC 11053 T were added together in commercially available substrates of different plant sources for fermentation. Proportionally added into GAM medium to observe the effect of various combinations of lactic acid bacteria on the growth of Ekman Muxophilus BCRC 81048 T.

2是含有混合植物乳桿菌BCRC 910891(A)、戊糖片球菌BCRC 11064(B)及戊醣乳酸桿菌BCRC 11053T(C)以市售不同植物來源為基質發酵的產物,對於艾克曼嗜黏蛋白菌BCRC 81048T生長的影響。由圖2結 果可得知,未經乳酸菌發酵過的薏仁汁、燕麥飲以及米漿中的成分,相對於GAM培養基,對於艾克曼嗜黏蛋白菌BCRC 81048T的生長刺激,助益。但是經過植物乳桿菌BCRC 910891與戊糖片球菌BCRC 11064或戊醣乳酸桿菌BCRC 11053T組合後的發酵物,對於艾克曼嗜黏蛋白菌BCRC 81048T的生長,均較原GAM培養基為佳。前述市售植物漿,以五穀雜糧或核果加水均質化的植物漿取代,也可以得到相似結果,五穀雜糧與核果包含小米、大米、麥、大豆、高粱、花生、薏仁、藜麥、薏仁、杏仁、芝麻、紅豆、綠豆、腰果。 Fig. 2 is the product that contains mixed Lactobacillus plantarum BCRC 910891 (A), Pediococcus pentosaceus BCRC 11064 (B) and Lactobacillus pentosus BCRC 11053 T (C) with commercially available different plant sources as substrates for fermentation. Effects of Mucinophilus BCRC 81048 T growth. From the results in Figure 2, it can be seen that the components in the barley juice, oat drink and rice milk that have not been fermented by lactic acid bacteria are beneficial to the growth stimulation of Ekman Muxophilus BCRC 81048 T compared to the GAM medium. However, the fermented product after combining Lactobacillus plantarum BCRC 910891 with Pediococcus pentosus BCRC 11064 or Lactobacillus pentosus BCRC 11053 T was better than the original GAM medium for the growth of Ekman Muxophilus BCRC 81048 T. The aforementioned commercially available vegetable pulp is replaced with the vegetable pulp of whole grains or stone fruits and water homogenization, and similar results can also be obtained. The whole grains and stone fruits include millet, rice, wheat, soybean, sorghum, peanut, barley, quinoa, barley, almond , sesame, red beans, mung beans, cashews.

透過本研究顯示,不同植物來源的基質,透過乳酸菌的發酵所得的產物,有助於艾克曼嗜黏蛋白菌得生長,未來可以作為培養艾克曼嗜黏蛋白菌的使用。 Through this study, it was shown that the products obtained from the fermentation of lactic acid bacteria from different plant-derived substrates are conducive to the growth of Ekman Muxophila, which can be used for the cultivation of Ekman Mucophila in the future.

實施例6 豆漿益生菌發酵品對糖尿病小鼠腸道菌相的影響 Example 6 The effect of soy milk probiotic fermentation product on the intestinal flora of diabetic mice

國立嘉義大學袁宏德碩士論文「高加價值發酵豆漿產品在Streptozotocin(STZ)誘導高血糖小鼠模式下的保護作用」教示L.plantarum發酵豆漿產品均對高血糖小鼠有顯著的保護作用,論文結果顯示鏈脲佐菌素(Streptozotocin;STZ)誘導為糖尿病鼠模式的小鼠,分別以無菌水(控制組)、豆漿(比較組)以及發酵豆漿乳酸菌產品(實驗組)餵食28天期間血糖濃度變化,實驗組小鼠的血糖自第7天起,就與控制組有顯著的差異,而此現象也持續平穩持續到實驗結束的第28天;實驗組小鼠的平均血糖,也與僅餵食豆漿的組別有明顯的差異;STZ糖尿病小鼠,在28天一般飲食飼養期間,血糖自220mg/dL不斷上升至400mg/dL;而餵食豆漿的組別,血糖自220mg/dL緩慢上升至320mg/dL附近,但經過發酵豆漿產品餵食,STZ的糖尿病 小鼠的血糖,在餵食期間,穩定維持在200-220mg/dL附近。由血糖的變化,可以明顯看出經過發酵豆漿產品,可以有效的控制血糖的急遽上升。因此本發明進一步知道使用L.plantarum BCRC 910891製成的豆漿益生菌發酵品是否可以改善糖尿病患的腸道菌相。 Yuan Hongde's master's thesis "High-value-added fermented soybean milk products in Streptozotocin (STZ)-induced hyperglycemia mice model" taught that L. plantarum fermented soybean milk products have significant protective effects on hyperglycemic mice. The results of the thesis Shows the changes of blood glucose concentration during 28 days after feeding with sterile water (control group), soy milk (comparison group) and fermented soymilk lactic acid bacteria product (experimental group) in mice with streptozotocin (Streptozotocin; STZ)-induced diabetic rat model. , the blood glucose of the mice in the experimental group was significantly different from the control group from the 7th day, and this phenomenon continued to be stable until the 28th day after the end of the experiment. In the STZ diabetic mice, the blood sugar increased from 220mg/dL to 400mg/dL continuously during the 28-day feeding period; while in the group fed with soy milk, the blood sugar slowly increased from 220mg/dL to 320mg/dL. Around dL, but after being fed with fermented soy milk products, the blood sugar of STZ diabetic mice was stably maintained at around 200-220 mg/dL during the feeding period. From the changes in blood sugar, it can be clearly seen that fermented soybean milk products can effectively control the rapid rise in blood sugar. Therefore, the present invention further knows whether the soymilk probiotic fermented product prepared by L. plantarum BCRC 910891 can improve the intestinal flora of diabetic patients.

使用30隻6週齡的無特定病源(specifid Pathogen-Free;SPF)小鼠(品系:C57/BL6;來源:國家實驗動物中心),C57/BL6小鼠禁食24小時後,腹腔注射(intraperitoneal injection)40mg/kg體重的鏈脲佐菌素(Streptozotocin或Streptozocin;簡稱STZ素;溶解於100mM檸檬酸鈉,pH 4.5)。首七日內,每天給予鏈脲佐菌素一次,共給予7次,建立小鼠糖尿病模式。七天後,以葡糖氧化酶(glucose oxidase)法測定血糖,以確認是否成功誘發糖尿病。當實驗期間無禁食的小鼠血糖質達250mg/dL時,則視為疾病模式建立成功。隨後實驗期間,每隔三天量測血糖一次,評估糖尿病小鼠的血糖濃度是利用市售的葡萄糖檢測套組(Glucose Assay Kit)(Sigma,USA)評估血液中葡糖糖含量。其中血糖濃度測試是在小鼠禁食4小時候進行採血。 Thirty 6-week-old 6-week-old Specified Pathogen-Free (SPF) mice (strain: C57/BL6; source: National Laboratory Animal Center) were used. injection) 40 mg/kg body weight of streptozotocin (Streptozotocin or Streptozocin; STZ for short; dissolved in 100 mM sodium citrate, pH 4.5). During the first seven days, streptozotocin was administered once a day for a total of 7 times to establish a diabetic model in mice. Seven days later, blood glucose was measured by the glucose oxidase method to confirm whether diabetes was successfully induced. When the blood glucose level of the unfasted mice reached 250 mg/dL during the experiment, the establishment of the disease model was considered to be successful. During the subsequent experiments, blood glucose was measured every three days, and the blood glucose concentration of the diabetic mice was evaluated by using a commercially available Glucose Assay Kit (Sigma, USA) to evaluate the glucose content in the blood. The blood glucose concentration test was performed when the mice were fasted for 4 hours.

每組有3隻雄性小鼠與3隻雌性小鼠,隨機分組。按小鼠體重計算每日管餵小鼠100μL無菌水,實驗組的小鼠每日每公斤的熟豆漿乳酸菌發酵品攝取量為250mg/Kg body weight/day或100mg/Kg body weight/day。比較組的小鼠每日每公斤的熟豆漿攝取量為250mg/Kg body weight/day或100mg/Kg body weight/day。控制組則給予無菌水。自注射鏈脲佐菌素完成建立小鼠糖尿病動物模式試驗起,每天投以一次,連續給予30天。C57/BL6小鼠飼養在無特定並源的正壓環境中,控溫保持在24℃,並 維持於12小時切換的光暗循環場域。飼養期間不限制飼料及水的供應。C57/BL6小鼠的飼養條件均依循國家衛生研究院公告的相關實驗動物管理指南進行。所有組別中的小鼠均經誘導糖尿病模式處理。實驗結束,犧牲小鼠,取得全小腸段,於-20℃凍存。 Each group consisted of 3 male mice and 3 female mice, randomly assigned. The mice were fed 100 μL of sterile water by tube every day according to the weight of the mice. The daily intake of the lactic acid bacteria fermented product per kilogram of cooked soybean milk for the mice in the experimental group was 250 mg/Kg body weight/day or 100 mg/Kg body weight/day. The daily intake of cooked soybean milk per kilogram of mice in the comparison group was 250 mg/Kg body weight/day or 100 mg/Kg body weight/day. The control group was given sterile water. Since the injection of streptozotocin completed the establishment of the mouse model of diabetes, it was administered once a day for 30 consecutive days. C57/BL6 mice were kept in a positive pressure environment without specific concurrency, and the temperature was kept at 24°C, and the The light-dark cycle field was maintained at a 12-hour switch. Feed and water supply were not restricted during the feeding period. The rearing conditions of C57/BL6 mice were carried out in accordance with the relevant laboratory animal management guidelines announced by the National Institutes of Health. Mice in all groups were treated with an induced diabetes model. At the end of the experiment, the mice were sacrificed, and whole small intestine sections were obtained, which were frozen at -20°C.

將凍存於-20℃的小鼠小腸,以滅菌過的剪刀剪開後,以滅菌後的刮勺,刮取腸黏膜,放置於PBS溶液中。利用vortex充分將黏膜上的菌體震盪出,以12000rpm轉速進行離心,將上清液除去後,再以PBS溶液,進行沉澱物清洗,重複三次後,得到的沉澱物,再以商用DNA萃取套組試劑QIAmp DNA Stool Mini kit(Qiagen),進行DNA萃取。所得到的DNA萃取物,保存於-20℃備用。進行腸道菌相分析,是利用細菌通用核醣體的16S rRNA引子,針對V4區域,引子序列如表3,例如正向引子F1可以與R1、R2、R3、R4四個反向引子的組合,加入萃取出的DNA樣品中,進行聚合酶連鎖反應,利用次世代基因定序(Next General Sequencing)方式,進行分析。 The mouse small intestine frozen at -20°C was cut open with sterilized scissors, and then the intestinal mucosa was scraped with a sterilized spatula and placed in a PBS solution. Use vortex to fully shake out the bacteria on the mucosa, centrifuge at 12,000 rpm, remove the supernatant, and then wash the precipitate with PBS solution. The set of reagents QIAmp DNA Stool Mini kit (Qiagen) was used for DNA extraction. The resulting DNA extract was stored at -20°C for later use. For the analysis of intestinal bacteria, the 16S rRNA primer of bacterial universal ribosome is used, and the primer sequence is shown in Table 3 for the V4 region. For example, the forward primer F1 can be combined with the four reverse primers R1, R2, R3, and R4. It is added to the extracted DNA sample, and the polymerase chain reaction is carried out, and the analysis is carried out by the next generation gene sequencing (Next General Sequencing) method.

Figure 108131848-A0101-12-0021-5
Figure 108131848-A0101-12-0021-5

A:Adenine;C:Cytosine;G:Guanine;T:Thymine;R:Guanine/Adenine(purine);Y:Cytosine/Thymine(pyrimidine);M:Adenine/Cytosine;S:Guanine/Cytosine D:Guanine/Adenine/Thymine;H:Adenine/Cytosine/Thymine;V:Guanine/Cytosine/ Adenine;N:Adenine/Guanine/Cytosine/Thymine。 A: Adenine; C: Cytosine; G: Guanine; T: Thymine; R: Guanine/Adenine(purine); Y: Cytosine/Thymine(pyrimidine); M: Adenine/Cytosine; S: Guanine/Cytosine D: Guanine/Adenine /Thymine; H: Adenine/Cytosine/Thymine; V: Guanine/Cytosine/ Adenine; N: Adenine/Guanine/Cytosine/Thymine.

將腸道菌群,依有益菌、有害菌以及伺機性菌等進行分類。圖3結果顯示STZ成功誘導的糖尿病模式小鼠,分別以熟豆漿(比較組)以及L.plantarum BCRC 910891發酵的熟豆漿乳酸菌發酵物(實驗組)餵食28天後的腸道菌相變化:餵食經BCRC 910891發酵的熟豆漿乳酸菌發酵物組別中,小鼠腸道中有益菌的比例達到77.6%,伺機性菌的比例為20.0%;而餵食熟豆漿的組別,小鼠腸道中有益菌的比例只達3.8%,明顯較有害菌所佔的49.4%為低,伺機性菌的比例(46.8%)和有害菌的比例相當;STZ成功誘導的糖尿病模式小鼠,以含有L.plantarum BCRC 910891發酵的熟豆漿乳酸菌發酵物,餵食28天後的腸道菌中的有益菌會較僅餵食熟豆漿組的腸道有益菌提升15倍以上。圖4結果顯示STZ成功誘導的糖尿病模式小鼠,分別比較熟豆漿(比較組)以及利用L.plantarum BCRC 910891發酵的熟豆漿乳酸菌發酵物(實驗組)餵食28天後的腸道中艾克曼嗜黏蛋白菌所佔的比例,明顯的發現,在餵食經過BCRC 910891發酵豆漿的實驗組中的小鼠腸道中的艾克曼嗜黏蛋白菌的比例高於僅餵食豆漿組的小鼠400倍。 The intestinal flora is classified into beneficial bacteria, harmful bacteria and opportunistic bacteria. Figure 3 shows the results of STZ-induced diabetes model mice, which were fed with cooked soybean milk (comparative group) and L. plantarum BCRC 910891 fermented lactic acid bacteria fermentation product (experimental group) for 28 days after feeding the intestinal bacteria phase changes: feeding In the group of cooked soybean milk lactic acid bacteria fermented by BCRC 910891, the proportion of beneficial bacteria in the intestinal tract of mice reached 77.6%, and the proportion of opportunistic bacteria was 20.0%; while in the group fed cooked soybean milk, the proportion of beneficial bacteria in the intestinal tract of mice reached 77.6%. The proportion is only 3.8%, which is obviously lower than the 49.4% of harmful bacteria, and the proportion of opportunistic bacteria ( 46.8 %) is similar to the proportion of harmful bacteria. The fermented cooked soybean milk lactic acid bacteria fermented product, after 28 days of feeding, the beneficial bacteria in the intestinal bacteria will increase by more than 15 times compared with the intestinal beneficial bacteria in the group fed only cooked soybean milk. Figure 4 shows the results of STZ-induced diabetes model mice, respectively, comparing the levels of Ekmania in the intestines of cooked soymilk (comparison group) and cooked soymilk lactic acid bacteria fermented with L. plantarum BCRC 910891 (experimental group) after feeding for 28 days The proportion of Mucinobacteria in the intestinal tract of mice in the experimental group fed with BCRC 910891 fermented soy milk was 400 times higher than that in mice fed only with soy milk.

綜上所述,本發明由台灣高山茶葉植栽篩選出的植物乳桿菌菌株BCRC 910891可以達成以下功效: To sum up, the Lactobacillus plantarum strain BCRC 910891 screened by Taiwan alpine tea planting in the present invention can achieve the following effects:

(1)BCRC 910891具有良好的黏稠性多醣生產能力,單獨使用或搭配其他益生菌都可以使豆類蛋白(豆漿)凝集成為不易離水的植物性凝態優格--豆漿乳酸菌發酵品。 (1) BCRC 910891 has a good production capacity of viscous polysaccharides. It can be used alone or in combination with other probiotics to agglomerate soy protein (soymilk) into a vegetable condensed state yogurt that is not easy to separate from water-soymilk lactic acid bacteria fermentation product.

(2)BCRC 910891製成的豆漿乳酸菌發酵品可以有效促進艾克曼嗜黏蛋白菌株(Akkermansia muciniphila)在腸道菌群中的比例、提升腸道中乳 酸菌含量以及優良菌相。 (2) The soymilk lactic acid bacteria fermented product made by BCRC 910891 can effectively promote the ratio of Akkermansia muciniphila in the intestinal flora, increase the content of lactic acid bacteria in the intestinal tract and improve the bacterial phase.

(3)BCRC 910891製成的豆漿乳酸菌發酵品中的γ-氨基丁酸含量可達20mg/100g以上、去醣基異黃酮佔總異黃酮量可達92%。 (3) The content of γ -aminobutyric acid in the soymilk lactic acid bacteria fermentation product made by BCRC 910891 can reach more than 20mg/100g, and the deglycosylated isoflavones can reach 92% of the total isoflavones.

(4)除豆類發酵品外,以BCRC 910891將燕麥、米、薏仁等製成的植物漿乳酸菌發酵品,亦可促進艾克曼嗜黏蛋白菌株(Akkermansia muciniphila)菌株生長。 (4) In addition to bean fermented products, the fermented products of plant pulp lactic acid bacteria made from oat, rice, barley, etc. according to BCRC 910891 can also promote the growth of Akkermansia muciniphila strains.

上列詳細說明係針對本發明之可行實施例之具體說明,惟該實施例並非用以限制本發明之專利範圍,凡未脫離本發明技藝精神所為之等效實施或變更,均應包含於本案之專利範圍中。 The above detailed descriptions are specific descriptions of feasible embodiments of the present invention, but the embodiments are not intended to limit the patent scope of the present invention. Any equivalent implementation or modification that does not depart from the technical spirit of the present invention shall be included in this case. within the scope of the patent.

上述多項功效,實屬充分符合新穎性及進步性之法定專利要件,爰依法提出申請,懇請 貴局核准本件發明專利申請案,以勵發明。 The above-mentioned functions are indeed in full compliance with the statutory patent requirements of novelty and progress, and you can file an application in accordance with the law.

【生物材料寄存】【Biological Material Deposit】 國內寄存資訊【請依寄存機構、日期、號碼順序註記】 Domestic storage information [please note in the order of storage institution, date and number]

1.財團法人食品工業發展研究所,寄存日期為2019年5月3日、寄存編號為BCRC 910891 1. The Food Industry Development Research Institute, a consortium, the deposit date is May 3, 2019, and the deposit number is BCRC 910891

國外寄存資訊【請依寄存國家、機構、日期、號碼順序註記】 Foreign deposit information [please note in the order of deposit country, institution, date and number]

1.中國微生物菌種保藏管理委員會普通微生物中心、寄存日期為2019年5月6日、寄存編號為CGMCC17716 1. General Microbiology Center of China Microorganism Culture Collection Management Committee, the deposit date is May 6, 2019, and the deposit number is CGMCC17716

<110> 歐斐生 <110> Orpheus

<120> 一種植物乳桿菌及其製備植物性凝態優格、改善腸道菌相的用途 <120> A Lactobacillus plantarum and its use for preparing vegetable condensed yogurt and improving intestinal flora

<130> PA20190394 <130> PA20190394

<160> 5 <160> 5

<170> PatentIn version 3.2 <170> PatentIn version 3.2

<210> 1 <210> 1

<211> 15 <211> 15

<212> DNA <212> DNA

<213> Artificial <213> Artificial

<220> <220>

<223> primer <223> primer

<400> 1

Figure 108131848-A0101-12-0024-6
<400> 1
Figure 108131848-A0101-12-0024-6

<210> 2 <210> 2

<211> 18 <211> 18

<212> DNA <212> DNA

<213> Artificial <213> Artificial

<220> <220>

<223> primer <223> primer

<400> 2

Figure 108131848-A0101-12-0025-7
<400> 2
Figure 108131848-A0101-12-0025-7

<210> 3 <210> 3

<211> 18 <211> 18

<212> DNA <212> DNA

<213> Artificial <213> Artificial

<220> <220>

<223> primer <223> primer

<400> 3

Figure 108131848-A0101-12-0026-9
<400> 3
Figure 108131848-A0101-12-0026-9

<210> 4 <210> 4

<211> 18 <211> 18

<212> DNA <212> DNA

<213> Artificial <213> Artificial

<220> <220>

<223> primer <223> primer

<400> 4

Figure 108131848-A0101-12-0026-8
<400> 4
Figure 108131848-A0101-12-0026-8

<210> 5 <210> 5

<211> 17 <211> 17

<212> DNA <212> DNA

<213> Artificial <213> Artificial

<220> <220>

<223> primer <223> primer

<400> 5

Figure 108131848-A0101-12-0027-10
<400> 5
Figure 108131848-A0101-12-0027-10

Claims (5)

一種新穎乳酸菌株,該菌為一種植物乳桿菌(Lactobacillus plantarum),其係寄存於中華民國食品工業發展研究所,寄存編號為BCRC910891,及寄存於中國微生物菌種保藏管理委員會普通微生物中心,寄存編號為CGMCC17716。 A novel lactic acid strain, the bacterium is a Lactobacillus plantarum , which is deposited in the Food Industry Development Research Institute of the Republic of China, the deposit number is BCRC910891, and is deposited in the General Microorganism Center of the China Microorganism Culture Collection Management Committee, the deposit number for CGMCC17716. 一種植物性凝態優格,是以植物漿加入益生菌製成,其中該益生菌包含植物乳桿菌(Lactobacillus plantarum),其係寄存於中華民國食品工業發展研究所,寄存編號為BCRC910891,及寄存於中國微生物菌種保藏管理委員會普通微生物中心,寄存編號為CGMCC17716;其中該植物性凝態優格的離水性小於25%,其中該植物漿是水與五穀雜糧、核果均質化所得;其中每100克該植物性凝態優格中的伽瑪胺基丁酸含量超過25毫克。 A vegetable condensed yogurt is prepared by adding probiotics to plant pulp, wherein the probiotics comprise Lactobacillus plantarum , which is deposited in the Food Industry Development Research Institute of the Republic of China, and the deposit number is BCRC910891, and the deposit number is BCRC910891. In the General Microbiology Center of the China Microbial Culture Collection Management Committee, the deposit number is CGMCC17716; wherein the water-free water of the vegetable condensed state yogurt is less than 25%, and the vegetable pulp is obtained by homogenizing water, whole grains and stone fruits; wherein each 100 The GABA content in this vegetable condensed yogurt exceeds 25 mg. 一種植物性凝態優格,是以植物漿加入益生菌製成,其中該益生菌包含植物乳桿菌(Lactobacillus plantarum),其係寄存於中華民國食品工業發展研究所,寄存編號為BCRC910891,及寄存於中國微生物菌種保藏管理委員會普通微生物中心,寄存編號為CGMCC17716;其中該植物性凝態優格的離水性小於25%,其中該植物漿是水與大豆均質化所得;其中每100克該植物性凝態優格中的伽瑪胺基丁酸含量超過25毫克;該植物性凝態優格中異黃酮的去醣基率超過80%。 A vegetable condensed yogurt is prepared by adding probiotics to plant pulp, wherein the probiotics comprise Lactobacillus plantarum, which is deposited in the Food Industry Development Research Institute of the Republic of China, and the deposit number is BCRC910891, and the deposit number is BCRC910891. In the General Microbiology Center of the China Microorganism Culture Collection Management Committee, the deposit number is CGMCC17716; wherein the water-free water of the vegetable condensed state yogurt is less than 25%, wherein the vegetable pulp is obtained by homogenizing water and soybean; wherein per 100 grams of the plant The content of gamma aminobutyric acid in the condensed yogurt exceeds 25 mg; the deglycosylation rate of isoflavones in the vegetable condensed yogurt exceeds 80%. 如申請專利範圍第23項所述的植物性凝態優格,可用於培養艾克曼嗜黏蛋白菌(Akkermansia muciniphilia)。 The plant-based condensed yogurt described in the second or third claim of the patent application can be used for culturing Akkermansia muciniphilia . 一種如申請專利範圍第23項的植物性凝態優格之用途,其係用於製備改善腸道菌相的醫藥組合物,其中該改善腸道菌相是腸道中艾克曼嗜黏 蛋白菌(Akkermansia muciniphilia)增加,其中該改善腸道菌相是改善糖尿病患者的腸道菌相。 A use of plant-based condensed yogurt as claimed in claim 2 or 3 of the scope of the application, which is used to prepare a pharmaceutical composition for improving intestinal bacteria, wherein the improving intestinal bacteria is Ekman's viscous admixture in the intestinal tract. Proteobacteria (Akkermansia muciniphilia) increased, wherein the improvement of intestinal flora is to improve the intestinal flora of diabetic patients.
TW108131848A 2019-09-04 2019-09-04 A kind of Lactobacillus plantarum and its use for preparing vegetable condensed yogurt and improving intestinal flora TWI766184B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
TW108131848A TWI766184B (en) 2019-09-04 2019-09-04 A kind of Lactobacillus plantarum and its use for preparing vegetable condensed yogurt and improving intestinal flora

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TW108131848A TWI766184B (en) 2019-09-04 2019-09-04 A kind of Lactobacillus plantarum and its use for preparing vegetable condensed yogurt and improving intestinal flora

Publications (2)

Publication Number Publication Date
TW202111112A TW202111112A (en) 2021-03-16
TWI766184B true TWI766184B (en) 2022-06-01

Family

ID=76035259

Family Applications (1)

Application Number Title Priority Date Filing Date
TW108131848A TWI766184B (en) 2019-09-04 2019-09-04 A kind of Lactobacillus plantarum and its use for preparing vegetable condensed yogurt and improving intestinal flora

Country Status (1)

Country Link
TW (1) TWI766184B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114480229B (en) * 2022-04-15 2022-08-09 微康益生菌(苏州)股份有限公司 Bifidobacterium animalis subsp lactis strain WKB148 and product and application thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108883143A (en) * 2015-11-08 2018-11-23 农场生物技术控股公司 Combined prebiotics and probiotic composition

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108883143A (en) * 2015-11-08 2018-11-23 农场生物技术控股公司 Combined prebiotics and probiotic composition

Also Published As

Publication number Publication date
TW202111112A (en) 2021-03-16

Similar Documents

Publication Publication Date Title
US10286026B2 (en) Probiotic fermented cereal compositions and methods for treatment of gastrointestinal diseases caused by pro-inflammatory bacteria
TWI241912B (en) Novel Acid-and bile salt-resistant Lactobacillus isolates having the ability to lower and assimilate cholesterol
KR20060135016A (en) Compostion comprising yucca extract, quillaia extract and lactic acid bacterium and food and drink containing the composition
WO2008012947A1 (en) Anti-fatty liver agent
CN103649304A (en) Isolated microorganism strains lactobacillus plantarum MCC2 DSM 23881 and lactobacillus gasseri MCC2 DSM 23882 and their use
CA2908032A1 (en) Composition containing bacterium belonging to genus lactobacillus
TW201705969A (en) Novel Lactobacillus mali APS1 and use thereof
JP5557483B2 (en) Lactobacillus strains and foods and pharmaceuticals containing the strains
TWI766184B (en) A kind of Lactobacillus plantarum and its use for preparing vegetable condensed yogurt and improving intestinal flora
CN116814501B (en) Bifidobacterium longum subspecies capable of relieving obesity and application thereof
KR101010913B1 (en) Lactobacillus plantarum having antihypertensive activity and fermented products containing it
JPWO2006112364A1 (en) Antihypertensive agent obtained by lactic acid bacteria culture
US20190240264A1 (en) Faecalibacterium longum and application thereof
CN112538439B (en) Lactobacillus plantarum and application thereof in preparing plant coagulated yoghurt and improving intestinal bacterial facies
JP6654639B2 (en) Blood tryptophan concentration increase inhibitor
JP5873904B1 (en) Composition for improving restless legs syndrome
CN116656526B (en) Lactobacillus plantarum JF4 and application thereof in preparation of blood sugar and cholesterol reducing foods and medicines
JP7008435B2 (en) Intestinal environment improving agent for the small intestine
Wu Mechanistic study of the effect of lactobacillus rhamnosus fermented soymilk on the progression of DOCA-salt induced hypertensive rats
KOWSALYA et al. A Review On Production Of Folate From Probiotic Bacteria
RU2548497C1 (en) Method for production of multi-purpose food additive with biocorrection properties
KR101827701B1 (en) functional fermented milk with emission of cholesterol and bile acid, and method for manufacturing the same
Nasri et al. A Review on The Benefits of Probiotics as Fermented Food against Several Diseases
BR102016010153A2 (en) DAIRY DRINK WITH BASE OF BABAÇU ALENDOA HYDRO-SOLUBLE EXTRACT AND ITS OBTAINING PROCESS WITH PROBIOTIC CULTURE
Wang et al. Effects of Buckwheat Milk Fermented by Four Probiotic Strains on Gut Microbiota and Production of Short-Chain Fatty Acids